Catawba Pediatric Associates PA

11/19/2025

So grateful for a night of painting, laughing, and unwinding with coworkers who are also great friends.❤️ A special thanks to Hip Hip Hoowray.

11/12/2025

11/12/2025

11/10/2025

11/10/2025

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/response-broader-fda-investigation-byheart-initiates-voluntary-recall-two-batches-infant-formula -announcement

[New York, NY] – ByHeart, a next-generation baby nutrition company, announced today that, out of an abundance of caution, it has chosen to voluntarily recall two batches of ByHeart Whole Nutrition Infant Formula following notification from the U.S. Food and Drug Administration (FDA) of a broader o...

11/07/2025

The U.S. eliminated measles in 2000, but rising cases are putting that status at risk. Over 1,600 infections have been confirmed this year, and experts say the true number may be higher. This week, an expert commission is meeting to review the latest measles data in the Americas. Canada is expected to be a top focus, with ongoing outbreaks since October 2024, while the U.S. and Mexico have outbreaks that began in January and February of 2025.

The AAP recommends all children receive the MMR vaccine at age 12-15 months, then again at 4-6 years to protect them from measles. Read more from AAP News at https://publications.aap.org/aapnews/news/33659/With-measles-elimination-status-at-risk?searchresult=1

11/01/2025

11/01/2025

As a parent, it’s understandable to want to learn about what’s in vaccines. But as you research, you might come across misleading claims about vaccine ingredients.

Antigens, for example, are a key ingredient in vaccines that help children’s immune systems learn to respond to viruses. Your children encounter antigens in many places they visit each day, including playgrounds. In fact, children can come in contact with up to 6,000 antigens each day.

If you have any additional questions about vaccines and their ingredients, talk with your pediatrician or click the link below.
https://bit.ly/430jf37

11/01/2025

Autistic children are valued members of our communities, deserving of support driven by high-quality research. Though preliminary studies have suggested the potential benefit of leucovorin for some autistic children, the evidence base remains too limited to support a wider recommendation. Questions on its benefits, dosing, appropriate monitoring and potential long-term impacts remain unanswered. Larger trials are needed to determine whether leucovorin is a safe and effective option for the autistic pediatric population.

AAP will update its guidance as evidence is compiled and encourages pediatricians to engage in shared decision-making with families asking about leucovorin while providing clear information about the evidence available and the potential risks. Learn more at the link below.
https://bit.ly/3WupJU7

10/31/2025

Wishing everyone a happy and safe Halloween!🎃